search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
166 new news items in the last 24 hours
  1. Home
  2. International

The AHEAD-MERIT trial will take place in 15 hospitals, targeting patients with aggressive HPV-associated cancers with an innovative vaccine.

Gabriel Dumitrache
whatsapp
facebook
linkedin
x
copy-link copy-link
8 August 2025, 08:43
main event image
International
Foto: Shutterstock
google-preference

Always see our news on Google

The AHEAD-MERIT clinical trial will take place in 15 hospitals in England, targeting patients with aggressive human papillomavirus (HPV)-associated cancers. These cancers have high rates of recurrence and poor survival. The vaccine being developed targets proteins commonly found in HPV-associated head and neck cancer. The health secretary declared the initiative a "huge victory" and NHS England is working with BioNTech to identify eligible patients. This is the third trial under the NHS Cancer Vaccine Launch Pad, which has already supported 550 patients.

Sources

sursa imagine
Mediafax
Vaccin revoluționar împotriva cancerului de cap și gât testat în Anglia
sursa imagine
independent.co.uk
Cancer patients to receive ‘game-changing’ vaccine in new NHS trial
sursa imagine
Stiripesurse
Vaccin revoluționar împotriva cancerului de cap și gât testat în Anglia

Latest News

18:04

Cristela Georgescu sent a “clarification” message regarding the postponement of the Ilfov Tribunal’s decision in her husband’s case

17:56

Constantin Toma calls for changes to the public procurement law and a reduction in bureaucracy, warning that delays are blocking local investments

17:49

Radu Oprea reaffirms Romania’s support for Ukraine and calls for increased security in the Black Sea

17:39

An AfD leader invites Elon Musk to invest in the state of Saxony-Anhalt and promises “favorable conditions for business”

17:29

Sorina Pintea, sentenced to three years and six months in prison for bribery, could be released on parole

See more news

NEWS ON THE SAME TOPICS

event image
International
An experimental cancer vaccine, developed by Moderna and Merck, has shown promising results in patients with melanoma.
event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
Health
Târgu Jiu County Hospital offers free HPV testing to women between 18 and 65 years old, from November 11 to December 28
event image
International
Russia will use the CaTeVac vaccine from 2027 to treat sarcomas
event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
Current Affairs
Cluj Oncology Institute represents Romania in the second stage of the European ECHoS project, dedicated to combating cancer
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
England United Kingdom mRNA cancer

Informat Moldova

main event image
Republic of Moldova
51 minutes ago

Moldova’s Ministry of Defense announces two incursions by a Geran-2 drone into the country’s airspace

Sources
imagine sursa
imagine sursa
imagine sursa
imagine sursa
imagine sursa

Editor’s Recommendations

main event image
INSCOP Surveys
8 hours ago

NOVEMBER 2026: Informat.ro – INSCOP Research BAROMETER, 15th Edition - Chapter VIII: What would Romanians do with 1 million euros?

main event image
Exclusive
1 hour ago

ANALYSIS Brexit without profit: London seeks reconciliation with the EU

main event image
International
6 hours ago

ANALYSIS The Kerch Bridge, between Putin’s symbol and Crimea’s supply route. The stakes of the Ukrainian attacks

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol